Meta-Analysis of Data from the Six Primary Prevention Trials of Cardiovascular Events Using Aspirin

This publication has 20 references indexed in Scilit:

• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
  New England Journal of Medicine, 2005
• An Update on Aspirin in the Primary Prevention of Cardiovascular Disease
  Archives of internal medicine (1960), 2003
• Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force
  Annals of Internal Medicine, 2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice
  The Lancet, 2001
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
  The Lancet, 1998
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
  The Lancet, 1998
• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989
• Randomised trial of prophylactic daily aspirin in British male doctors
  BMJ, 1988
• Meta‐analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co‐operative trials
  Statistics in Medicine, 1987